Leaderboard

En | De
Sie sind hier: Onkologie » Respirationstrakt 14. August 2026
Suchen
medline.ch
Respirationstrakt
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8065  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 161281  
   
Risk of fracture among lung cancer survivors by cancer treatment modality: A population-based retrospective cohort study.
J Bone Oncol
Kim S, Han KD, Jung J, Yoon DW, Cho JH, Shin DW.
PMID: 42598301 [PubMed]


The Role of F-18 FDG PET/CT in the Evaluation of Solitary Pulmonary Nodules.
Saudi Med J
Cetinkaya E, Guzel F, Tuzcu SA, Cetin IE, Ibiloglu I, Argin E, Cetin FA, Tasdemir B.
PMID: 42598094 [PubMed - indexed for MEDLINE]


Beyond chemotherapy: The rise of nucleic acid nanoformulations in personalized lung cancer therapy.
Cancer Pathog Ther
Hermain S, K S H, Nimbagal RN.
PMID: 42597591 [PubMed]


Preoperative inflammation-based biomarkers and postoperative pulmonary complications after lung resection for lung cancer: a systematic review with selective exploratory quantitative synthesis.
Front Surg
Zhu X, Long C, Zhu X, Xu S, Shao W.
PMID: 42597369 [PubMed]


Incidence and risk factors of infections in lung cancer patients receiving immunotherapy combined with chemotherapy: a real-world retrospective study.
Am J Cancer Res
Zou J, Ji G, Yan L, Li J, Zhang Y, Pi D.
PMID: 42597257 [PubMed]


Clinical value of serum osteocalcin (N-MID) combined with thyroid transcription factor-1 for predicting bone metastasis of lung cancer.
Am J Cancer Res
Li Y, Wu B, Zhou W.
PMID: 42597206 [PubMed]


Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
J Med Internet Res
Jiang Z, Xu Y, Jia S, Liu H.
PMID: 42596052 [PubMed - indexed for MEDLINE]


Malnutrition Severity, Morphofunctional Assessment, and Survival in Patients with Lung Cancer: A Multicentre Prospective Cohort Study.
Lung
Rodríguez de Vera-Gómez P, Galindo-Gallardo M, González-Pacheco M, Carmona-Llanos A, Zarco-Martín MT, Palmas-Candia FX, Carmen Roque-Cuéllar MDC, Muñoz-Garach A, Muñoz-Jiménez C, Rebollo-Pérez MI, Mustieles V, Fernández-Jiménez R, Fernández-Soto ML, García-Almeida JM.
PMID: 42595921 [PubMed - indexed for MEDLINE]


TP53 Mutation and Tumor-Infiltrating Lymphocytes as Predictors of PD-1/PD-L1 Inhibitor Efficacy in PD-L1-High Advanced NSCLC.
Cancer Rep (Hoboken)
Yan H, Xu Q, Zheng Y, Shen M, Li D.
PMID: 42595871 [PubMed - indexed for MEDLINE]


ΔAverage of long and short axis diameter on non-contrast CT is associated with major pathological response to neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Eur Radiol
Liu J, Xie M, Liu Y, Shen J, Yao J, Bao X, Zhang X, Wu J, Xue X.
PMID: 42595861 [PubMed - as supplied by publisher]


Targeting the Ubiquitin-Proteasome System: An Emerging Paradigm for Overcoming Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
Exp Cell Res
Chen R, Zhu H, Zhou K, Xie J.
PMID: 42595292 [PubMed - as supplied by publisher]


Comparing Different Planning Strategies for Pencil Beam Scanning Carbon Ion Radiotherapy for Stage I Peripheral Non-Small Lung Cancer: Toward Optimized Clinical Decision-Making.
Int J Radiat Oncol Biol Phys
Lu Y, Chen J, Sheng Y, Wang W, Mao J.
PMID: 42595262 [PubMed - as supplied by publisher]


SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.
Cancer Cell
Li ZM, Zhou Z, He ZY, Han L, Fang J, Sun HM, Liu HF, Wang MX, Liu YB, Qu XJ, Yao Y, Gong Y, Yu Y, Shi HQ, Wang Y, Su CX, Yang KY, Shang YH, Ruan J, Yuan XL, Zhang MJ, Luo H, Cui JW, Lin XY, Li MX, Lou HZ, Yang RX, Wu H, Wang XC, Dan M, Zhang LQ, Su YZ, Wan XC, Zou K, Yang YY, Lu S.
PMID: 42594871 [PubMed - as supplied by publisher]


The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study.
J Int Med Res
Wei H, Han W, Zhang X, Zhao J.
PMID: 42593353 [PubMed - indexed for MEDLINE]


Significant differences in volatile organic compounds and interleukin-12 (IL-12) serum levels between lung cancer patients and healthy controls: a cross-sectional study.
Med Glas (Zenica)
Nurandhini M, Setyawan UA, Listyoko AS, Djajalaksana S, Ponco Wardoyo AY.
PMID: 42592994 [PubMed - indexed for MEDLINE]


Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer.
Thorac Cancer
Yan R, Yisilamu P, Ge Y, Zhou W.
PMID: 42592881 [PubMed - indexed for MEDLINE]


Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors.
Thorac Cancer
Laffi A, Lamberti G, La Salvia A.
PMID: 42592685 [PubMed - indexed for MEDLINE]


Superior sulcus tumor with vertebral invasion following initial diagnosis of cavitary lung disease: a case report.
AME Case Rep
Gritsiuta AI, Radfar P, Nishi SP, Petrov RV.
PMID: 42592347 [PubMed]


Tumor-SAM: Segment Anything Model for Semi-automatic Lung Tumor Segmentation in CT.
Proc SPIE Int Soc Opt Eng
Xie L, Tong Y, Wu C, Torigian DA, Udupa JK, Wan Y.
PMID: 42592330 [PubMed]


Prognostic value of gut microbiota-derived metabolites in non-small cell lung cancer: a retrospective cohort study of overall survival.
Transl Cancer Res
Pan H, Chen X, Wu W, Wang M, Wang Y.
PMID: 42591787 [PubMed]


   
   Artikel 1 - 20 / 161281    Seite 1 von 8065  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1